Ins and Outs of Kinase DFG Motifs

Slides:



Advertisements
Similar presentations
Development of Antibiotic Activity Profile Screening for the Classification and Discovery of Natural Product Antibiotics Weng Ruh Wong, Allen G. Oliver,
Advertisements

Biocompatible Quantum Dots for Biological Applications Sandra J. Rosenthal, Jerry C. Chang, Oleg Kovtun, James R. McBride, Ian D. Tomlinson Chemistry &
Proteasome Inhibitors: An Expanding Army Attacking a Unique Target Alexei F. Kisselev, Wouter A. van der Linden, Herman S. Overkleeft Chemistry & Biology.
Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Sweetly Expanding Enzymatic Glycodiversification
Nucleosomes and Cisplatin
An Unnatural PIP Simulates Growth Factor Signaling
Volume 22, Issue 5, Pages v-vi (May 2015)
Ambiguous Origin: Two Sides of an Ephrin Receptor Tyrosine Kinase
Nucleosomes and Cisplatin
Antibiotics: A New Hope
Foundations for Directed Alkaloid Biosynthesis
Deubiquitination of Lys63-Linkage by a CYLD UBP
Arvin C. Dar, Michael S. Lopez, Kevan M. Shokat  Chemistry & Biology 
Crystal Structures of Sirt3 Complexes with 4′-Bromo-Resveratrol Reveal Binding Sites and Inhibition Mechanism  Giang Thi Tuyet Nguyen, Melanie Gertz,
Volume 21, Issue 11, Pages (November 2014)
Ready, Set, Go! How Protein Kinase C Manages Dynamic Signaling
Adding Specificity to Artificial Transcription Activators
Finding the Missing Code of RNA Recognition by PUF Proteins
Deubiquitination of Lys63-Linkage by a CYLD UBP
JAK3 Specific Kinase Inhibitors: When Specificity Is Not Enough
Targeting the Undruggable Proteome: The Small Molecules of My Dreams
Volume 14, Issue 5, Pages (May 2007)
Traffic Jam at the Bacterial Sec Translocase: Targeting the SecA Nanomotor by Small- Molecule Inhibitors  Kenneth Segers, Jozef Anné  Chemistry & Biology 
Bioactive Cell-Penetrating Peptides: Kill Two Birds with One Stone
No Need To Be Pure: Mix the Cultures!
Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
Volume 26, Issue 1, Pages e5 (January 2019)
Riboswitches: Fold and Function
Seisuke Yamashita, Kozo Tomita  Structure 
HAT Trick: p300, Small Molecule, Inhibitor
BCR-ABL1 Kinase: Hunting an Elusive Target with New Weapons
A General Strategy for Creating “Inactive-Conformation” Abl Inhibitors
Making a New Turn In Matrix Metalloprotease Inhibition
Sanjay B. Hari, Ethan A. Merritt, Dustin J. Maly  Chemistry & Biology 
Sachin Surade, Tom L. Blundell  Chemistry & Biology 
Volume 21, Issue 8, Pages v-vi (August 2014)
Volume 12, Issue 11, Pages (November 2005)
Volume 13, Issue 2, Pages (February 2006)
Foundations for Directed Alkaloid Biosynthesis
Volume 16, Issue 5, Pages (May 2009)
Volume 42, Issue 1, Pages 9-22 (April 2011)
Volume 18, Issue 8, Pages (August 2011)
Volume 15, Issue 3, Pages (March 2008)
Volume 20, Issue 2, Pages (February 2013)
Remodeling KRAS Structure
Volume 17, Issue 11, Pages (November 2010)
Conformation-Selective ATP-Competitive Inhibitors Control Regulatory Interactions and Noncatalytic Functions of Mitogen-Activated Protein Kinases  Sanjay B.
Volume 11, Issue 12, Pages (December 2004)
Matthias P. Müller, Daniel Rauh  Cell Chemical Biology 
L-DOPA Ropes in tRNAPhe
Volume 7, Issue 6, Pages R147-R151 (June 2000)
Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Ethan B. Butler, Yong Xiong, Jimin Wang, Scott A. Strobel 
Structural Basis of Swinholide A Binding to Actin
Harnessing the Antioxidant Power with ARE-Inducing Compounds
Ramon Hurtado-Guerrero, Daan M.F. van Aalten  Chemistry & Biology 
Volume 21, Issue 9, Pages (September 2014)
Volume 21, Issue 7, Pages (July 2014)
Arvin C. Dar, Michael S. Lopez, Kevan M. Shokat  Chemistry & Biology 
Self-Assembling, Dynamic αPNAs
Clemens C. Heikaus, Jayvardhan Pandit, Rachel E. Klevit  Structure 
Tag-Team SUMO Wrestling
Tools to Tackle Protein Acetylation
Structural Basis of RIP1 Inhibition by Necrostatins
Volume 15, Issue 6, Pages (June 2008)
A General Strategy for Creating “Inactive-Conformation” Abl Inhibitors
Peter Man-Un Ung, Rayees Rahman, Avner Schlessinger 
Volume 21, Issue 9, Pages (September 2014)
A Molecular View of Anti-ErbB Monoclonal Antibody Therapy
Presentation transcript:

Ins and Outs of Kinase DFG Motifs Daniel K. Treiber, Neil P. Shah  Chemistry & Biology  Volume 20, Issue 6, Pages 745-746 (June 2013) DOI: 10.1016/j.chembiol.2013.06.001 Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 1 DFG-In and -Out Conformations of Inhibitor-Bound ABL (A) Cocrystal structure of the type I inhibitor VX-680 (gray) bound to ABL (cyan) (Young et al., 2006). The activation loop (yellow) adopts the active DFG-in conformation. The gatekeeper and xDFG residues shown by Hari et al. (2013) to govern DFG conformation are indicated by orange and magenta circles, respectively. (B) Cocrystal structure of the type II inhibitor imatinib (gray) bound to ABL (cyan) (Nagar et al., 2002). The activation loop adopts the inactive-DFG-out conformation exposing the allosteric pocket (transparent, yellow circle) occupied by imatinib. In (A), this pocket is occupied by the DFG motif, which adopts the “in” conformation. Chemistry & Biology 2013 20, 745-746DOI: (10.1016/j.chembiol.2013.06.001) Copyright © 2013 Elsevier Ltd Terms and Conditions